Arlckon Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 1.20 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 Cr
- Revenue Growth %
- Profit Growth 37.66%
- Ebitda -8.84%
- Net Worth -12.00%
- Total Assets 48.92%
About Arlckon Biotech
Arlckon Biotech Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 February 2021 (Three years and 11 months 18 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹4.50 Cr.
Lalit Chopade, Ravindra Chopade, Arun Chopade, and Three other members serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2021PTC355143
-
Company No.
355143
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Feb 2021
-
Date of AGM
20 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Arlckon Biotech?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Chopade
|
Director | 12-Feb-2021 | Current |
|
Ravindra Chopade
|
Director | 12-Feb-2021 | Current |
|
Arun Chopade
|
Director | 12-Feb-2021 | Current |
|
Hemangini Chopade
|
Director | 12-Feb-2021 | Current |
|
Nayana Chopade
|
Director | 12-Feb-2021 | Current |
|
Manisha Chopade
|
Director | 12-Feb-2021 | Current |
Financial Performance of Arlckon Biotech.
Arlckon Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 37.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arlckon Biotech?
Unlock access to Arlckon Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Alr Pharmatech Limited Liability Partner ShipLalit Chopade and Arun Chopade are mutual person
Charges (Loans)
₹45.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2024 | Others | ₹1.50 Cr | Open |
| 20 Feb 2023 | Others | ₹3.00 Cr | Open |
How Many Employees Work at Arlckon Biotech?
Arlckon Biotech has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arlckon Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arlckon Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.